Probiotics and Mental Health: Can Gut Bacteria Affect Your Mood?
What human trials suggest about probiotics, depression and anxiety—and how to make sense of strains, product labels and safety.

In this article
Could supporting the gut become another way to support mental health? Probiotic research offers encouraging signs, including studies in people whose depression has not fully improved with medication. The most useful question is which product may help which person, alongside their existing care.1
What are probiotics?
Probiotics are live microorganisms intended to provide a health benefit. They include certain bacteria and yeasts and can be found in some foods and supplements. A particular strain matters: one type of a bacterium can have different effects from another.2
Prebiotics are different. They are nondigestible food components that support the growth or activity of helpful microorganisms. A product combining probiotics and prebiotics is called a synbiotic.2
The gut-brain connection: several possible pathways
Researchers are studying how changes in gut microbes might influence the body through microbial metabolites, gut-barrier function, and immune, hormonal or nervous-system responses. Different probiotics may act through different pathways; there is no single universal mechanism behind the label.3
A 2025 analysis of the same depression pilot discussed below found some changes in gut bacteria associated with anxiety improvement, but no difference in the measured inflammatory markers. It was a small mechanistic study with missing data. Its value is in helping identify possible pathways, rather than showing that every probiotic lowers inflammation or explains mood improvement in the same way.4
What do studies in people show?
In a 2023 placebo-controlled pilot, 50 people with major depression and an incomplete response to antidepressants were enrolled; 49 received the study intervention. They continued their medication and took a multistrain probiotic or placebo for eight weeks. The probiotic group showed encouraging improvements on some depression and anxiety measures, with good adherence and no serious adverse reactions. It was designed to inform a larger trial, rather than settle treatment effectiveness.1
A 2026 pilot in 58 adults aged 60 or older also tested probiotics alongside antidepressant care. It reported modest overall advantages in depression and anxiety scores, but the groups' improvement trajectories were largely parallel and more than half the participants were lost over 24 weeks. The findings invite further testing rather than a broad claim of benefit in all older adults.5
Results also depend on the product and population. An eight-week 2025 trial of Limosilactobacillus reuteri in depressed patients with overweight and low-grade inflammation found no overall advantage over placebo on its primary or secondary outcomes in the 75-person analysis.6
Together, these studies keep the potential interesting while pointing toward more targeted use. A positive result with one preparation does not make every probiotic interchangeable.16
Choosing a probiotic: evidence before bigger numbers
The original article favored more strains and a higher colony-forming unit count, or CFU. A better guide is the evidence for the particular formulation. CFU describes viable microorganisms; a bigger number does not automatically mean a better health effect.3
- Look for the genus, species and strain identification, not only a broad label such as Lactobacillus.3
- Ask whether the product and dose match human studies for the concern you want to address.3
- Check storage instructions and the viable count through the expiration date, rather than only at manufacture.3
Where do fermented foods fit?
Foods such as yogurt can contain live microorganisms, but not every fermented food contains a probiotic with a demonstrated health benefit. A food can belong in an enjoyable eating pattern without being equivalent to a preparation tested in a depression trial.3
Safety and a sensible trial plan
Probiotics are often well tolerated, but safety information is incomplete and effects vary. Serious infections have occurred, particularly in people who are severely ill or have weakened immune systems. Those groups need medical guidance before considering a live-microorganism supplement.2
If you and your clinician decide a trial is reasonable, agree on the product, the goal, when to review it and what would lead you to stop. Track mood, anxiety and digestive symptoms separately. Keep prescribed treatment in place unless your prescriber recommends a change.
The Anxious Resistance take
As someone who has experienced anxiety, I understand why another possible avenue for relief matters. I find this research hopeful because it broadens the conversation about care. I would approach probiotics as a specific option to discuss, with realistic expectations and a way to judge whether they are helping.
The opportunity is to build on a treatment plan that fits you. Curiosity about the gut-brain connection can sit alongside medication, therapy and other support, without turning a supplement into a promise.
By Birk Gundersen, RN, BSN.
References
- Nikolova et al. (2023) — placebo-controlled pilot of probiotics added to antidepressants, JAMA Psychiatry
- NCCIH — probiotic definitions, variation between strains and safety considerations
- NIH Office of Dietary Supplements — mechanisms, strain-specific evidence, CFUs, food sources and product selection
- Nikolova et al. (2025) — microbiota and inflammatory-marker analysis of the same depression pilot
- Sinha et al. (2026) — PRODG pilot trial in older adults with depression
- Söderberg Veibäck et al. (2025) — placebo-controlled L. reuteri trial in depression with low-grade inflammation
